Category Archives: Muscular Dystrophy Treatment

Muscular Dystrophy Stop the Gradual Decline in Health !! 3.83/5 (76.52%) 23 votes Is it just the starting stage? Call us today to know how Welling Homeopathy can help you totally recover from muscular dystrophy. We have an extensive experience of more than 12 years to customise the treatment for you as required. Call (+91) 80 80 850 950 or (022) 24306343 to meet our experts today. The more you delay, the more difficult it becomesfor us to help you. There has been gradual increase in the number of children & adults with Muscular Dystrophy we are seeing every month. In our monthly review last week, we noticed that we had seen a spurt of patient visiting us for the treatment of Muscular Dystrophy. But we also noticed that many people keep suffering without knowing thatMuscular Dystrophy can be helped with proper Homeopathy treatment forMuscular Dystrophy in the initial stages and offer a pallative treatment forMuscular Dystrophy in the advanced stages. And what are the options for the treatment ofMuscular Dystrophy? Muscular Dystrophy isa general term for a number of hereditary, progressive degenerative disorders affecting skeletal muscles, and often other organ It is a group of genetic diseases characterized by … Continue reading →

What Is Duchenne Muscular Dystrophy? Muscular dystrophies are a group of diseases that make muscles weaker and less flexible over time. Duchenne muscular dystrophy (DMD) is the most common type. Its caused by flaws in the gene that controls how the body keeps muscles healthy. The disease almost always affects boys, and symptoms usually begin early in childhood. Children with DMD have a hard time standing up, walking, and climbing stairs. Many eventually need wheelchairs to get around. They can also have heart and lung problems. Although there isn't a cure, the outlook for people with DMD is better than it has ever been. Years ago, children with the disease usually didnt live beyond their teens. Today, they live well into their 30s, and sometimes into their 40s and 50s. There are therapies that can ease symptoms, and researchers are looking for new ones, as well. DMD is caused by a problem in one of your genes. Genes contain the information your body needs to make proteins, which carry out many different body functions. If you have DMD, the gene that makes a protein called dystrophin is broken. This protein normally keeps muscles strong and protects them from injury. The … Continue reading →

Learning About Duchenne Muscular Dystrophy What is Duchenne muscular dystrophy? Duchenne muscular dystrophy (DMD) is a rapidly progressive form of muscular dystrophy that occurs primarily in boys. It is caused by an alteration (mutation) in a gene, called the DMD gene that can be inherited in families in an X-linked recessive fashion, but it often occurs in people from families without a known family history of the condition. Individuals who have DMD have progressive loss of muscle function and weakness, which begins in the lower limbs. The DMD gene is the second largest gene to date, which encodes the muscle protein, dystrophin. Boys with Duchenne muscular dystrophy do not make the dystrophin protein in their muscles. Duchenne muscular dystrophy affects approximately 1 in 3500 male births worldwide. Because this is an inherited disorder, risks include a family history of Duchenne muscular dystrophy. Top of page The symptoms usually appear before age 6 and may appear as early as infancy. Typically, the first noticeable symptom is delay of motor milestones, including sitting and standing independently. The mean age for walking in boys with Duchenne muscular dystrophy is 18 months. There is progressive muscle weakness of the legs and pelvic muscles, which … Continue reading →

Likely Genetic Source of Muscle Weakness Found in Six Previously Undiagnosed Children Apr. 9, 2015 Using state-of-the-art genetic technology, researchers have discovered the likely cause of a child's rare type of severe muscle weakness. The child was one of six cases in which investigators ... read more Scientists Identify New Disease Treatment Path Jan. 26, 2015 A previously unknown phenomenon -- that diseased muscle cells literally eat themselves to death -- has been discovered by researchers. The researchers say this previously unrecognised mechanism could ... read more Hope for Muscular Dystrophy Patients: Harnessing Gene Helps Repair Muscle Damage Jan. 15, 2015 Researchers have successfully improved the ability of muscle to repair itself -- by artificially increasing levels of the BMI1 gene in the muscle-specific stem cells of mice with muscular ... read more Jan. 12, 2015 Researchers have developed a way to measure upper extremity movement in patients with muscular dystrophy using interactive video game technology. Their hope is to expand inclusion criteria for ... read more Dec. 30, 2014 Early use of available heart failure drugs slows the progressive decline in heart function before symptoms are apparent in boys and young men with Duchenne muscular dystrophy (DMD), according to … Continue reading →

(Duchenne Muscular Dystrophy, Becker's Muscular Dystrophy, Facioscapulohumeral Muscular Dystrophy, Limb-Girdle Muscular Dystrophies) The Facts on Muscular Dystrophy Muscular dystrophy is a term that refers to a group of muscle disorders in which the face, arm, leg, spine, or heart muscles gradually shrink and weaken over time. This can lead to many physical limitations, and in some forms of muscular dystrophy, shortened life spans. Muscle disorders run in families, and most forms start in childhood. There are a variety of types of muscular dystrophy, including: The different types are distinguished by factors such as the: Muscular dystrophy is rare. For example, although Duchenne Muscular Dystrophy is one of the more common types, it occurs in only 1 out of every 50,000 people. The other types of muscular dystrophy are even rarer. All muscular dystrophies are inherited. Each type of muscular dystrophy is associated with a distinct genetic mutation. The nature of the gene mutation and which chromosome it is located on determine the characteristics of the muscular dystrophy and the way the disease is passed from one generation to the next. The gene responsible for Duchenne and Becker's muscular dystrophies normally produces a protein called dystrophin, which helps muscle cells keep … Continue reading →

What Is Muscular Dystrophy? Muscular dystrophy is a group of diseases that make muscles weaker and less flexible over time. It is caused by a problem in the genes that control how the body keeps muscles healthy. For some people, the disease starts early in childhood. Others dont have any symptoms until they are teenagers or middle-aged adults. How muscular dystrophy affects you or your child depends on the kind. Most peoples condition will get worse over time, and some people may lose the ability to walk, talk, or care for themselves. But that doesnt happen to everyone. Other people can live for many years with mild symptoms. U.S. Children's Medical Needs, by the Numbers Racing champ Jeff Gordon's focus on children's health comes at a crucial time. The number of U.S. children with chronic health conditions has risen dramatically in the past four decades, according to a study published last June in The Journal of the American Medical Association. Some of the study's findings: Of 80 million children in America, about 8% (6.5 million) have chronic conditions that interfere with regular daily activity, says study author James M. Perrin, MD, professor of pediatrics... Read the U.S. Children's Medical Needs, … Continue reading →

SAN RAFAEL, Calif., Jun 08, 2015 (GLOBE NEWSWIRE via COMTEX) -- BioMarin Pharmaceutical Inc. BMRN, -2.62% announced today the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for drisapersen, an investigational antisense oligonucleotide drug candidate for the treatment of the largest subset of Duchenne muscular dystrophy (DMD) amenable to single exon skipping. DMD is the most common fatal genetic disorder diagnosed in childhood, affecting approximately 1 in every 3,500 live male births with about 20,000 new cases diagnosed globally each year. In Europe, it is estimated there are 23,000 boys with Duchenne Muscular Dystrophy, and approximately 3,000 of those would be candidates for drisapersen.In BioMarin's commercial territories, approximately 85 percent of Duchenne patients are located outside of the United States, including Western Europe, Middle East, Eastern Europe, Latin America and Japan. Western Europe has the largest patient population among those areas, exceeding the United States by around 30 percent. Drisapersen induces the skipping of dystrophin exon 51, potentially providing a therapeutic benefit to DMD patients for whom skipping of exon 51 restores the proper dystrophin reading frame, corresponding to approximately 13% of DMD patients. The company recently submitted a New Drug Application (NDA) to the … Continue reading →

Breast Cancer Gene in 1% of U.S. Jews September 29, 1995, Friday - By GINA KOLATA - National Desk - 1684 Words In a new insight into the genetic basis of breast cancer, biologists have discovered that a particular genetic defect is found with unusual frequency in American Jews whose ancestors lived in Eastern and Central Europe. The discovery does not seem likely to lead immediately to any new treatment,... September 28, 1995, Thursday - By GINA KOLATA - National Desk - 687 Words Two rigorous studies of gene therapy have found that it failed to benefit patients with cystic fibrosis or Duchenne muscular dystrophy. The diseases are caused by mutated genes, and in each case the hope was that if a good gene could be added to cells that lack it, it might correct the defect in... January 17, 1995, Tuesday - By NATALIE ANGIER - Science Desk; - 1363 Words WHENEVER a lot of very good scientists spend years searching single-mindedly for a high-profile disease gene, they invariably begin fishing out all sorts of candidate genes that look, smell and wiggle like the real thing, but then prove to be frustrating red herrings. In the course of seeking … Continue reading →

Israeli pharmaceutical company BioBlast Pharma Ltd.(Nasdaq:ORPN) has announced that it has received US Food and Drug Administration (FDA) approval for fast track clinical trials of Cabaletta, its leading product, for treatment of oculopharyngeal muscular dystrophy (OPMD), a rare muscular disease. The fast track provides a company with better access to FDA staff in devising the trial procedures for products, with the aim of attaining more rapid approval when the trials results are submitted. Such approval is usually given only for diseases for which there is currently no treatment. Founded by Dr. Dalia Megiddo and Udi Gilboa, BioBlast has acquired a number of technologies for treating genetically caused diseases. All the diseases that BioBlast is attempting to treat are rare diseases, but all the technologies it has acquired are designed for treatment of several such diseases, so the company's technological potential is designed to suit the general market. Its leading product is for OPMD, a deadly disease with several dozen patients in Israel and several hundred in the US. A Phase II/III trials is currently taking place in Israel and China, with the US scheduled for inclusion soon. BioBlast's current market cap is $99 million. The company share has plummeted 37% … Continue reading →

Mayopathys Home - Muscular Dystrophy Treatment in Tamilnadu Best Muscular Dystrophy Treatment in Ayurveda, Celebral Palsy Treatment, Clapfoot Treatment in Tamilnadu, By: … Continue reading →